Keyword search
More options
/
Help
Go to year:
Content
Home
Current winners & finalists
Past winners & finalists by category
How to enter
Prize luncheon
Prize seminars
Press releases
In the news
FAQ
Contact
Links
The Prizes
The Board
honoring
Excellence
in journalism
and the arts
since 1917
E-mail this page
« Back to Awards for 2001
The 2001 Pulitzer Prize Winners
Investigative Reporting
Current tab: works
David Willman
In order of appearance in the original entry
December 20, 2000
NEW FDA: How a New Policy Led to Seven Deadly Drugs
December 20, 2000
NEW FDA: Propulsid
December 20, 2000
NEW FDA: Raxar
December 20, 2000
NEW FDA: Redux
December 20, 2000
NEW FDA: Duract
December 20, 2000
NEW FDA: Posicor
December 20, 2000
NEW FDA: Lotronex
December 20, 2000
NEW FDA: Rezulin
December 20, 2000
NEW FDA: Relenza
February 19, 2000
Key Physician Urges Rezulin Be Withdrawn
March 10, 2000
Fears Grow Over Delay in Removing Rezulin
March 17, 2000
Physician Who Opposes Rezulin Is Threatened by FDA With Dismissal
March 22, 2000
Diabetes Drug Rezulin Pulled Off the Market
August 16, 2000
FDA's Approval and Delay in Withdrawing Rezulin Probed
November 16, 2000
FDA Post-Mortem Finds Drug Approval Problems
November 2, 2000
FDA Minimized Issue of Lotronex's Safety
November 29, 2000
Drug Lotronex Pulled Over Safety Fears